The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on...
from NDTV News - India-news https://www.ndtv.com/india-news/drugs-controller-general-of-india-seeks-clarification-from-glenmark-on-its-covid-19-drug-favipiravir-2265504
No comments:
Post a Comment